Johnson & Johnson (JNJ) Gains from Sales and Divestitures (2013 - 2026)
Johnson & Johnson (JNJ) reported Gains from Sales and Divestitures of -$16 million for Q3 2026, compared with $57 million a year earlier.
Powered by 
Analysis
Johnson & Johnson (JNJ) Gains from Sales and Divestitures (2013 - 2026) Analysis & Trends
Over the twelve months ended Sep 27, 2026, Johnson & Johnson's Gains from Sales and Divestitures came in at $159 million, up 20.5% year-over-year; for FY2025, it was $263 million, up 16.4% from FY2024.
- Gains from Sales and Divestitures has a four-year compound annual growth rate of 24.1% (FY2021 to FY2025).
- By year, Gains from Sales and Divestitures came in at $226 million in FY2024 (-98.9%), $20.98 billion in FY2023, $380 million in FY2022 and $111 million in FY2021.
- The Q3 2026 figure ranks as the lowest quarterly Gains from Sales and Divestitures since Q4 2022.
- Per Business Quant data, the three quarters before Q3 2026 came in at $55 million (Q2 2026), -$12 million (Q1 2026) and $132 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn |
| 10 | Vertex Pharmaceuticals | 136.55 Bn | 104.28 Bn | 2.91 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 27, 2026 | -16.00 Mn |
| Jun 28, 2026 | 55.00 Mn |
| Mar 29, 2026 | -12.00 Mn |
| Dec 28, 2025 | 132.00 Mn |
| Sep 28, 2025 | 57.00 Mn |
| Jun 29, 2025 | -1.00 Mn |
| Mar 30, 2025 | 75.00 Mn |
| Dec 29, 2024 | 1.00 Mn |
| Sep 29, 2024 | 20.98 Bn |
| Jun 30, 2024 | 223.00 Mn |
| Oct 1, 2023 | 20.98 Bn |
| Jul 2, 2023 | 39.00 Mn |
| Apr 2, 2023 | 8.00 Mn |
| Dec 31, 2022 | -380.00 Mn |
| Apr 3, 2022 | 168.00 Mn |
| Dec 31, 2021 | -617.00 Mn |
| Jul 4, 2021 | 21.00 Mn |
| Apr 4, 2021 | 580.00 Mn |
| Jun 28, 2020 | 60.00 Mn |
| Dec 29, 2019 | 29.00 Mn |
API Access
Johnson & Johnson Gains from Sales and Divestitures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=JNJ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gains-from-sales-and-divestitures", "ticker": "JNJ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=JNJ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();